Day Range2.880 - 3.100 | 52 Wk Range0.542 - 3.450 | Open / Close3.090 / 2.910 | Float / Outstanding23.093M / 38.929M |
Vol / Avg.339.171K / 1.016M | Mkt Cap113.283M | P/E- | 50d Avg. Price1.770 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float23.093M | EPS-1.640 |
BeyondSpring Stock (NASDAQ: BYSI) stock price, news, charts, stock research, profile.
Day Range2.880 - 3.100 | 52 Wk Range0.542 - 3.450 | Open / Close3.090 / 2.910 | Float / Outstanding23.093M / 38.929M |
Vol / Avg.339.171K / 1.016M | Mkt Cap113.283M | P/E- | 50d Avg. Price1.770 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float23.093M | EPS-1.640 |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-05-01 | ||||||
REV |
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) 2023-02-21 | ||||||
REV | 340.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of BeyondSpring (NASDAQ: BYSI) through any online brokerage.
Other companies in BeyondSpring’s space includes: Graphite Bio (NASDAQ:GRPH), Galectin Therapeutics (NASDAQ:GALT), Inozyme Pharma (NASDAQ:INZY), Immuneering (NASDAQ:IMRX) and Sesen Bio (NASDAQ:SESN).
The latest price target for BeyondSpring (NASDAQ: BYSI) was reported by Jefferies on Thursday, December 2, 2021. The analyst firm set a price target for 5.00 expecting BYSI to rise to within 12 months (a possible 71.82% upside). 0 analyst firms have reported ratings in the last year.
The stock price for BeyondSpring (NASDAQ: BYSI) is $2.91 last updated February 8, 2023 at 9:00 PM UTC.
There are no upcoming dividends for BeyondSpring.
BeyondSpring’s Q3 earnings are confirmed for Monday, May 1, 2023.
There is no upcoming split for BeyondSpring.
BeyondSpring is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
BeyondSpring Stock (NASDAQ: BYSI) stock price, news, charts, stock research, profile.
Day Range2.880 - 3.100 | 52 Wk Range0.542 - 3.450 | Open / Close3.090 / 2.910 | Float / Outstanding23.093M / 38.929M |
Vol / Avg.339.171K / 1.016M | Mkt Cap113.283M | P/E- | 50d Avg. Price1.770 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float23.093M | EPS-1.640 |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-05-01 | ||||||
REV |
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) 2023-02-21 | ||||||
REV | 340.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of BeyondSpring (NASDAQ: BYSI) through any online brokerage.
Other companies in BeyondSpring’s space includes: Graphite Bio (NASDAQ:GRPH), Galectin Therapeutics (NASDAQ:GALT), Inozyme Pharma (NASDAQ:INZY), Immuneering (NASDAQ:IMRX) and Sesen Bio (NASDAQ:SESN).
The latest price target for BeyondSpring (NASDAQ: BYSI) was reported by Jefferies on Thursday, December 2, 2021. The analyst firm set a price target for 5.00 expecting BYSI to rise to within 12 months (a possible 71.82% upside). 0 analyst firms have reported ratings in the last year.
The stock price for BeyondSpring (NASDAQ: BYSI) is $2.91 last updated February 8, 2023 at 9:00 PM UTC.
There are no upcoming dividends for BeyondSpring.
BeyondSpring’s Q3 earnings are confirmed for Monday, May 1, 2023.
There is no upcoming split for BeyondSpring.
BeyondSpring is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
BeyondSpring Stock (NASDAQ: BYSI) stock price, news, charts, stock research, profile.
Day Range2.880 - 3.100 | 52 Wk Range0.542 - 3.450 | Open / Close3.090 / 2.910 | Float / Outstanding23.093M / 38.929M |
Vol / Avg.339.171K / 1.016M | Mkt Cap113.283M | P/E- | 50d Avg. Price1.770 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float23.093M | EPS-1.640 |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-05-01 | ||||||
REV |
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) 2023-02-21 | ||||||
REV | 340.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of BeyondSpring (NASDAQ: BYSI) through any online brokerage.
Other companies in BeyondSpring’s space includes: Graphite Bio (NASDAQ:GRPH), Galectin Therapeutics (NASDAQ:GALT), Inozyme Pharma (NASDAQ:INZY), Immuneering (NASDAQ:IMRX) and Sesen Bio (NASDAQ:SESN).
The latest price target for BeyondSpring (NASDAQ: BYSI) was reported by Jefferies on Thursday, December 2, 2021. The analyst firm set a price target for 5.00 expecting BYSI to rise to within 12 months (a possible 71.82% upside). 0 analyst firms have reported ratings in the last year.
The stock price for BeyondSpring (NASDAQ: BYSI) is $2.91 last updated February 8, 2023 at 9:00 PM UTC.
There are no upcoming dividends for BeyondSpring.
BeyondSpring’s Q3 earnings are confirmed for Monday, May 1, 2023.
There is no upcoming split for BeyondSpring.
BeyondSpring is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
BeyondSpring Stock (NASDAQ: BYSI) stock price, news, charts, stock research, profile.
Day Range2.880 - 3.100 | 52 Wk Range0.542 - 3.450 | Open / Close3.090 / 2.910 | Float / Outstanding23.093M / 38.929M |
Vol / Avg.339.171K / 1.016M | Mkt Cap113.283M | P/E- | 50d Avg. Price1.770 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float23.093M | EPS-1.640 |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-05-01 | ||||||
REV |
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) 2023-02-21 | ||||||
REV | 340.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of BeyondSpring (NASDAQ: BYSI) through any online brokerage.
Other companies in BeyondSpring’s space includes: Graphite Bio (NASDAQ:GRPH), Galectin Therapeutics (NASDAQ:GALT), Inozyme Pharma (NASDAQ:INZY), Immuneering (NASDAQ:IMRX) and Sesen Bio (NASDAQ:SESN).
The latest price target for BeyondSpring (NASDAQ: BYSI) was reported by Jefferies on Thursday, December 2, 2021. The analyst firm set a price target for 5.00 expecting BYSI to rise to within 12 months (a possible 71.82% upside). 0 analyst firms have reported ratings in the last year.
The stock price for BeyondSpring (NASDAQ: BYSI) is $2.91 last updated February 8, 2023 at 9:00 PM UTC.
There are no upcoming dividends for BeyondSpring.
BeyondSpring’s Q3 earnings are confirmed for Monday, May 1, 2023.
There is no upcoming split for BeyondSpring.
BeyondSpring is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
BeyondSpring Stock (NASDAQ: BYSI) stock price, news, charts, stock research, profile.
Day Range2.880 - 3.100 | 52 Wk Range0.542 - 3.450 | Open / Close3.090 / 2.910 | Float / Outstanding23.093M / 38.929M |
Vol / Avg.339.171K / 1.016M | Mkt Cap113.283M | P/E- | 50d Avg. Price1.770 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float23.093M | EPS-1.640 |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-05-01 | ||||||
REV |
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) 2023-02-21 | ||||||
REV | 340.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of BeyondSpring (NASDAQ: BYSI) through any online brokerage.
Other companies in BeyondSpring’s space includes: Graphite Bio (NASDAQ:GRPH), Galectin Therapeutics (NASDAQ:GALT), Inozyme Pharma (NASDAQ:INZY), Immuneering (NASDAQ:IMRX) and Sesen Bio (NASDAQ:SESN).
The latest price target for BeyondSpring (NASDAQ: BYSI) was reported by Jefferies on Thursday, December 2, 2021. The analyst firm set a price target for 5.00 expecting BYSI to rise to within 12 months (a possible 71.82% upside). 0 analyst firms have reported ratings in the last year.
The stock price for BeyondSpring (NASDAQ: BYSI) is $2.91 last updated February 8, 2023 at 9:00 PM UTC.
There are no upcoming dividends for BeyondSpring.
BeyondSpring’s Q3 earnings are confirmed for Monday, May 1, 2023.
There is no upcoming split for BeyondSpring.
BeyondSpring is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
BeyondSpring Stock (NASDAQ: BYSI) stock price, news, charts, stock research, profile.
Day Range2.880 - 3.100 | 52 Wk Range0.542 - 3.450 | Open / Close3.090 / 2.910 | Float / Outstanding23.093M / 38.929M |
Vol / Avg.339.171K / 1.016M | Mkt Cap113.283M | P/E- | 50d Avg. Price1.770 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float23.093M | EPS-1.640 |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-05-01 | ||||||
REV |
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) 2023-02-21 | ||||||
REV | 340.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of BeyondSpring (NASDAQ: BYSI) through any online brokerage.
Other companies in BeyondSpring’s space includes: Graphite Bio (NASDAQ:GRPH), Galectin Therapeutics (NASDAQ:GALT), Inozyme Pharma (NASDAQ:INZY), Immuneering (NASDAQ:IMRX) and Sesen Bio (NASDAQ:SESN).
The latest price target for BeyondSpring (NASDAQ: BYSI) was reported by Jefferies on Thursday, December 2, 2021. The analyst firm set a price target for 5.00 expecting BYSI to rise to within 12 months (a possible 71.82% upside). 0 analyst firms have reported ratings in the last year.
The stock price for BeyondSpring (NASDAQ: BYSI) is $2.91 last updated February 8, 2023 at 9:00 PM UTC.
There are no upcoming dividends for BeyondSpring.
BeyondSpring’s Q3 earnings are confirmed for Monday, May 1, 2023.
There is no upcoming split for BeyondSpring.
BeyondSpring is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
BeyondSpring Stock (NASDAQ: BYSI) stock price, news, charts, stock research, profile.
Day Range2.880 - 3.100 | 52 Wk Range0.542 - 3.450 | Open / Close3.090 / 2.910 | Float / Outstanding23.093M / 38.929M |
Vol / Avg.339.171K / 1.016M | Mkt Cap113.283M | P/E- | 50d Avg. Price1.770 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float23.093M | EPS-1.640 |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-05-01 | ||||||
REV |
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) 2023-02-21 | ||||||
REV | 340.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of BeyondSpring (NASDAQ: BYSI) through any online brokerage.
Other companies in BeyondSpring’s space includes: Graphite Bio (NASDAQ:GRPH), Galectin Therapeutics (NASDAQ:GALT), Inozyme Pharma (NASDAQ:INZY), Immuneering (NASDAQ:IMRX) and Sesen Bio (NASDAQ:SESN).
The latest price target for BeyondSpring (NASDAQ: BYSI) was reported by Jefferies on Thursday, December 2, 2021. The analyst firm set a price target for 5.00 expecting BYSI to rise to within 12 months (a possible 71.82% upside). 0 analyst firms have reported ratings in the last year.
The stock price for BeyondSpring (NASDAQ: BYSI) is $2.91 last updated February 8, 2023 at 9:00 PM UTC.
There are no upcoming dividends for BeyondSpring.
BeyondSpring’s Q3 earnings are confirmed for Monday, May 1, 2023.
There is no upcoming split for BeyondSpring.
BeyondSpring is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
BeyondSpring Stock (NASDAQ: BYSI) stock price, news, charts, stock research, profile.
Day Range2.880 - 3.100 | 52 Wk Range0.542 - 3.450 | Open / Close3.090 / 2.910 | Float / Outstanding23.093M / 38.929M |
Vol / Avg.339.171K / 1.016M | Mkt Cap113.283M | P/E- | 50d Avg. Price1.770 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float23.093M | EPS-1.640 |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-05-01 | ||||||
REV |
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) 2023-02-21 | ||||||
REV | 340.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of BeyondSpring (NASDAQ: BYSI) through any online brokerage.
Other companies in BeyondSpring’s space includes: Graphite Bio (NASDAQ:GRPH), Galectin Therapeutics (NASDAQ:GALT), Inozyme Pharma (NASDAQ:INZY), Immuneering (NASDAQ:IMRX) and Sesen Bio (NASDAQ:SESN).
The latest price target for BeyondSpring (NASDAQ: BYSI) was reported by Jefferies on Thursday, December 2, 2021. The analyst firm set a price target for 5.00 expecting BYSI to rise to within 12 months (a possible 71.82% upside). 0 analyst firms have reported ratings in the last year.
The stock price for BeyondSpring (NASDAQ: BYSI) is $2.91 last updated February 8, 2023 at 9:00 PM UTC.
There are no upcoming dividends for BeyondSpring.
BeyondSpring’s Q3 earnings are confirmed for Monday, May 1, 2023.
There is no upcoming split for BeyondSpring.
BeyondSpring is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
BeyondSpring Stock (NASDAQ: BYSI) stock price, news, charts, stock research, profile.
Day Range2.880 - 3.100 | 52 Wk Range0.542 - 3.450 | Open / Close3.090 / 2.910 | Float / Outstanding23.093M / 38.929M |
Vol / Avg.339.171K / 1.016M | Mkt Cap113.283M | P/E- | 50d Avg. Price1.770 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float23.093M | EPS-1.640 |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-05-01 | ||||||
REV |
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) 2023-02-21 | ||||||
REV | 340.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of BeyondSpring (NASDAQ: BYSI) through any online brokerage.
Other companies in BeyondSpring’s space includes: Graphite Bio (NASDAQ:GRPH), Galectin Therapeutics (NASDAQ:GALT), Inozyme Pharma (NASDAQ:INZY), Immuneering (NASDAQ:IMRX) and Sesen Bio (NASDAQ:SESN).
The latest price target for BeyondSpring (NASDAQ: BYSI) was reported by Jefferies on Thursday, December 2, 2021. The analyst firm set a price target for 5.00 expecting BYSI to rise to within 12 months (a possible 71.82% upside). 0 analyst firms have reported ratings in the last year.
The stock price for BeyondSpring (NASDAQ: BYSI) is $2.91 last updated February 8, 2023 at 9:00 PM UTC.
There are no upcoming dividends for BeyondSpring.
BeyondSpring’s Q3 earnings are confirmed for Monday, May 1, 2023.
There is no upcoming split for BeyondSpring.
BeyondSpring is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.